The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4 + and CD8 + tumor-infiltrating lymphocytes. - Reader CS; Liao W; Potter-Landua BJ; Veyssier CS; Seal CJ; Brewis N; Morrow M (Anti-cancer drugs, 2025)